Archive - Biodraft

The “Blockbuster Dilemma” in Biotech

We studied ~10 commercial-stage companies and learned about this interesting theme. Amgen, Genentech, Biogen, Regeneron, Vertex, Gilead, Celgene…

Sep 11, 2022 •

Liang Chang

and

Kirill Karlin

10

November 2021

Deep-dive into platform biotech companies: phenotypes, business models, destinations...

We studied over 30 platform companies and share what we have learned. Moderna, Alnylam, Intellia, Recursion, Ginkgo, Kite, Genentech...

Nov 1, 2021 •

and

September 2021

Therapeutics around the central dogma: DNA

A study note on gene therapy and gene editing landscape: MoA and delivery

Sep 16, 2021 •

A short readme about our biotech blog

Sep 15, 2021 •

Liang Chang

and

Kirill Karlin

8

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Biodraft_

November 2021

September 2021